Arrowhead Pharmaceuticals (STU:HDP1) Total Assets : €878.74 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Total Assets?

Arrowhead Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was €878.74 Mil.

Warning Sign:

If a company builds assets at 57.5% a year, faster than its revenue growth rate of 47.5% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Arrowhead Pharmaceuticals's average Total Assets Growth Rate was 5.30% per year. During the past 3 years, the average Total Assets Growth Rate was 20.50% per year. During the past 5 years, the average Total Assets Growth Rate was 57.50% per year. During the past 10 years, the average Total Assets Growth Rate was 42.50% per year.

During the past 13 years, Arrowhead Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 420.80%. The lowest was -18.50%. And the median was 27.25%.

Total Assets is connected with ROA %. Arrowhead Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 was -63.47%. Total Assets is also linked to Revenue through Asset Turnover. Arrowhead Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Arrowhead Pharmaceuticals Total Assets Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Total Assets Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Assets

Get a 7-Day Free Trial

317.66

443.61

603.63

698.86

717.32

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															832.48	734.58	717.32	574.30	878.74

Arrowhead Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Arrowhead Pharmaceuticals's Total Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (A: Sep. 2023 )	+	Total Liabilities (A: Sep. 2023 )
	=	269.071	+	448.251
	=	717.32

Arrowhead Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	455.773	+	422.965
	=	878.74

Arrowhead Pharmaceuticals (STU:HDP1) Total Assets Explanation

Total Assets is connected with ROA %.

Arrowhead Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-461.104	/	( (574.304	+	878.738)	/ 2 )
	=	-461.104	/	726.521
	=	-63.47 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Arrowhead Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (574.304	+	878.738)	/ 2 )
=	0	/	726.521
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Arrowhead Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines